Patent details

Basic Information

Publication number:

EP3431076

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP181742743

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMPROVED LIPID FORMULATION

French Title of Invention:

FORMULATION LIPIDIQUE AMÉLIORÉE

German Title of Invention:

VERBESSERTE LIPIDFORMULIERUNG

SPC Number:

Dates

Filing date:

10/06/2010

Grant date:

06/10/2021

EP Publication Date:

23/01/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/10/2021

EP B1 Publication Date:

06/10/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

10/06/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/09/2021

 

 

Name:

Arbutus Biopharma Corporation

Address:

100- 8900 Glenlyon Parkway, Burnaby, BC V5J 5J8, Canada (CA)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

07/10/2021

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

JAYARAMAN, Muthusamy

Address:

United States (US)

2

Name:

QIN, Xiaojun

Address:

United States (US)

3

Name:

AKINC, Akin

Address:

United States (US)

4

Name:

NARAYANANNAIR, Jayaprakash, K.

Address:

United States (US)

5

Name:

ANSELL, Steven

Address:

United States (US)

6

Name:

CHEN, Jianxin

Address:

United States (US)

7

Name:

DORKIN, Joseph, R.

Address:

United States (US)

8

Name:

CANTLEY, William

Address:

United States (US)

9

Name:

MANOHARAN, Muthiah

Address:

United States (US)

10

Name:

RAJEEV, Kallanthottathil, G.

Address:

United States (US)

Priority

1

Priority Number:

18580009 P

Priority Date:

10/06/2009

Priority Country:

United States (US)

2

Priority Number:

24483409 P

Priority Date:

22/09/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/127; C07C 211/00; A61K 31/20; C12N 5/00; A61K 48/00; A61K 47/50; A61P 9/00; A61P 25/28;

Publication

European Patent Bulletin

Issue number:

202140

Publication date:

06/10/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/06/2025

Annual Fee Number:

16

Annual Fee Amount:

230 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/05/2024

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
07/10/2021	Power Of Attorney	1
07/10/2021	Outgoing Correspondence	1